The urology unit of the Federal Teaching Hospital, Lokoja, has inaugurated its maiden prostate cancer support group meeting to improve patients’ lives.
The initiative is supported by the Inclusive Cancer Care Research Equity Consortium for Black Men, with a research initiative to examine the incidence of anxiety and depression and determine the quality of life for patients.
Prostate cancer affects black men, who face significantly higher risks of diagnosis and mortality compared to men of other races.
In the United States, one in six black men is said to develop prostate cancer in their lifetime, compared to one in eight men in the general population.
Ayodeji Ogunmola, team leader and principal investigator of i-CARE, FTH Lokoja, said the meeting would improve patients’ clinical attendance.
He noted that the meeting was a follow-up to a summit held on November 11, 2025, which brought together stakeholders to discuss ways to tackle prostate cancer in Kogi.
The urologist emphasised the importance of regular check-ups, especially for men over 45 years, to detect prostate cancer early.
Mr Ogunmola urged participants to share their experiences and support one another by promoting a culture of openness and awareness.
He called on Nigerians to prioritise their health by undergoing regular check-ups, especially for prostate cancer.
The urologist attributed the high incidence of prostate cancer among men to a lack of regular check-ups and awareness.
Mr Ogunmola said the group would meet monthly to raise awareness and promote men’s health, urging patients to ask questions freely and share their feelings without reservation.
The meeting attracted participants from various local government areas in the state, including doctors, health experts, and patients.
Taiwo Jones, the site principal investigator of the Prostate Cancer Transatlantic Consortium, said the meeting would provide a platform for patients to share experiences and receive support.
The meeting featured lectures, free prostate-specific antigen tests, access to urologists, caregiver training, and opportunities to share experiences with fellow patients.
It also featured lectures on clinical and psychological challenges and the importance of support for men living with prostate cancer.
Some participants, including John Bolarin and Joseph Titus, expressed gratitude to the hospital for organising the event, adding that it helped them manage their condition and lifestyle.
The i-CARE Consortium, founded by Folake Odediran, aims to reduce prostate cancer’s impact on black men through research, education, and support.
(NAN)